Healthcare – Page 5 – Alston & Bird PFAS Primer

Assessment of perfluorooctanoic acid toxicity in pancreatic cells

ByPFAS Primer Team January 8, 2021March 25, 2021

Results indicate oxidative stress plays a role in PFOA-induced pancreatic toxicity and highlight the incidence of inflammation with PFOA exposure. January 8, 2021 | Toxicology in Vitro

PFAS Science Updates

Prenatal exposure to per- and polyfluoroalkyl substances in association with autism spectrum disorder in the MARBLES study

ByPFAS Primer Team December 30, 2020March 16, 2021

Study observed increased risk of autism spectrum disorder in children exposed to PFOA an PFNA. December 30, 2020 | Environment International

PFAS Science Updates

PFAS and cancer, a scoping review of the epidemiologic evidence

ByPFAS Primer Team December 30, 2020March 16, 2021

Overall, the evidence for an association between cancer and PFAS remains sparse. December 30, 2020 | Environmental Research

The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy

ByPFAS Primer Team December 24, 2020February 9, 2021

Associations between PFAS concentrations and lipid profiles in pregnant women might differ by trimesters of pregnancy. December 24, 2020 | Ecotoxicology and Environmental Safety

Prenatal Exposure to Per- and Polyfluoroalkyl Substances, Umbilical Cord Blood DNA Methylation, and Cardio-Metabolic Indicators in Newborns: The Healthy Start Study

ByPFAS Primer Team December 24, 2020February 9, 2021

Study estimated associations of prenatal PFAS with DNA methylation in umbilical cord blood. We evaluated associations of methylation at selected sites with neonatal cardio-metabolic indicators. December 24, 2020 | Environmental Health Perspectives